Article info

Download PDFPDF

Association between prescription of hypnotics/anxiolytics and mortality in multimorbid and non-multimorbid patients: a longitudinal cohort study in primary care

Authors

  • Kristjan Linnet Development Centre for Primary Healthcare in Iceland, Primary Health Care of the Capital Area, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Johann Agust Sigurdsson Development Centre for Primary Healthcare in Iceland, Primary Health Care of the Capital Area, Reykjavik, Iceland General Practice Research Unit, Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway PubMed articlesGoogle scholar articles
  • Margret Olafia Tomasdottir Department of Family Medicine, Faculty of Medicine, University of Iceland School of Health Sciences, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Emil Larus Sigurdsson Development Centre for Primary Healthcare in Iceland, Primary Health Care of the Capital Area, Reykjavik, Iceland Department of Family Medicine, Faculty of Medicine, University of Iceland School of Health Sciences, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Larus Steinthor Gudmundsson Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  1. Correspondence to Kristjan Linnet; kristjan.linnet{at}heilsugaeslan.is
View Full Text

Citation

Linnet K, Sigurdsson JA, Tomasdottir MO, et al
Association between prescription of hypnotics/anxiolytics and mortality in multimorbid and non-multimorbid patients: a longitudinal cohort study in primary care

Publication history

  • Received August 9, 2019
  • Revised October 31, 2019
  • Accepted November 12, 2019
  • First published December 5, 2019.
Online issue publication 
December 05, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.